期刊文献+

Wnt/β-catenin通路与肝星状细胞的活化、增殖 被引量:7

Role of Wnt/β-catenin pathway in activation and proliferation of hepatic stellate cells
下载PDF
导出
摘要 肝纤维化是指各种致病因子导致肝细胞炎症、坏死,肝脏中胶原蛋白等细胞外基质(extracellular matrix)降解与沉积失衡,进而导致肝脏内结缔组织异常增生的病理状态.在肝纤维化的形成过程中,肝星状细胞为主要效应细胞.肝星状细胞的激活、分泌细胞外基质、过度的细胞外基质的沉积是形成肝纤维化的中心环节.Wnt/β-catenin通路参与器官纤维化的机制并没有被明确,但已有文献报道Wnt信号通路参与到器官纤维化和肝纤维化的过程中.国内外也均有研究证实Wnt/β-catenin通路与肝星状细胞的活化增殖、肝纤维化存在着一定的关系. Liver fibrosis refers to a pathological state in which a variety of pathogenic factors lead to hepatocyte inflammation and necrosis, the imbalance between degradation and deposition of collagen and other extracellular matrix (ECM) molecules, and the abnormal proliferation of liver connective tissue. In the process of the formation of hepatic fibrosis, hepatic stellate cells are the major contributor. Activated hepatic stellate cells secrete extracellular matrix components, and excessive deposition of extracellular matrix is the central event in liver fibrosis. Currently, there have been many articles reporting that the Wnt/β-catenin signaling pathway is involved in organ fibrosis and liver fibrosis, but the underlying mechanism has not been clearly clarified. Some studies have also confirmed that there is a certain relationshipbetween the Wnt/β-catenin pathway and activa- tion of hepatic stellate cells in liver fibrosis.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第5期609-614,共6页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.81173180/H2704 福建省自然科学基金资助项目 No.2011J01216~~
关键词 肝纤维化 肝星状细胞 WNT β-catenin通路 Hepatic fibrosis Hepatic stellate cells Wnt/β-catenin signaling
  • 相关文献

参考文献50

  • 1Zhang DW, Zhao YX, Wei D, Li YL, Zhang Y, Wu J, Xu J, Chen C, Tang H, Zhang W, Gong L, Han Y, Chen ZN, Bian H. HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis. J Hepatol 2012; 57:1283-1291 [PMID: 22878468 DOI: 10.1016/ j.jhep.2012.07.042]. 被引量:1
  • 2Friedman SL. Hepatic fibrosis - overview. Toxicology 2008; 254:120-129 [PMID: 18662740 DOI: 10.1016/ j.tox.2008.06.013]. 被引量:1
  • 3Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta 2006; 364:33-60 [PMID: 16139830]. 被引量:1
  • 4Atzori L, Poli G, Perra A. Hepatic stellate cell: a star cell in the liver. Int J Biochem Cell Biol 2009; 41:1639-1642 [PMID: 19433304 DOI: 10.1016/j.biocel.2009.03.001]. 被引量:1
  • 5Alatas FS, Masumoto K, Matsuura T, Hayashida M, Saeki I, Kohashi K, Oda Y, Taguchi T. Synchronized expressions of hepatic stellate cells and their trans- activation and liver regeneration during liver injury in an animal model of cholestasis. J Pediatr Surg 2011; 46:2284-2290 [PMID: 22152866 DOI: 10.1016/ j.jpedsurg.2011.09.016]. 被引量:1
  • 6Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011; 25:195-206 [PMID: 21497738 DOI: 10.1016/ j.bpg.2011.02.005]. 被引量:1
  • 7Forbes SJ, Parola M. Liver fibrogenic cells. Best Pract Res Clin Gastroenterol 2011; 25:207-217 [PMID: 21497739 DOI: 10.1016/j.bpg.2011.02.006]. 被引量:1
  • 8Kong D, Zhang F, Zhang Z, Lu Y, Zheng S. Clear- ance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational poten- tial. Biomed Pharmacother 2013; 67:246-250 [PMID: 23201010 DOI: 10.1016/j.biopha.2012.10.002]. 被引量:1
  • 9Kim do Y, Chung SI, Ro SW, Paik YH, Lee JI, Jung MK, Lee MG, Park YN, Lee KS, Park JG, Park HD, Han KH. Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibro- sis in rats. Apoptosis 2013; 18:1481-1491 [PMID: 24045874 DOI: 10.1007/s10495-013-0896-5]. 被引量:1
  • 10Kisseleva T, Brenner DA. Anti-fibrogenic strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol 2011; 25:305-317 [PMID: 21497747 DOI: 10.1016/j.bpg.2011.02.011]. 被引量:1

二级参考文献90

共引文献21

同被引文献128

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部